BPC 157 For Knee Pain: Early Reported Outcomes A report on intra articular BPC 157 for knee pain described high rates of improvement: ~92% with BPC 157 alone, ~75% when combined with thymosin beta 4, and overall BPC 157 Data: Promising, But Not Proven In Humans Early animal studies suggest BPC 157 may reduce pain behaviors in inflammatory and non inflammatory models, including reduced allodynia. But this does not establish human clinical Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review IgA Vasculitis NIDDK